Evidence-Based Reviews

Methamphetamine-induced psychosis: Who says all drug use is reversible?

Author and Disclosure Information

Treatment needs to take into account persistent cognitive impairment and comorbid disorders



Use of methamphetamine, an N-methyl analog of amphetamine, is a serious public health problem; throughout the world an estimated 35.7 million people use the drug recreationally.1 Methamphetamine is easy to obtain because it is cheap to produce and can be synthesized anywhere. In the United States, methamphetamine is commonly manufactured in small-scale laboratories using relatively inexpensive, legally available ingredients. Large-scale manufacturing in clandestine laboratories also contributes to methamphetamine abuse. The drug, known as meth, crystal meth, ice, and other names, is available as a powder, tablet, or crystalline salt, and is used by various routes of administration (Table).

The basis for methamphetamine abuse/dependence lies with the basic biochemical effects of the drug on the brain, where it functions as a potent releaser of monoamines,2 including dopamine, in brain regions that subsume rewarding effects of various substances, including food and sexual activities.3 These biochemical effects occur through the binding of the drug to dopamine transporters and vesicular monoamine transporter 2.2

Although FDA-approved for treating attention-deficit/hyperactivity disorder, methamphetamine is taken recreationally for its euphoric effects; however, it also produces anhedonia, paranoia, and a host of cognitive deficits and other adverse effects.

Methamphetamine causes psychiatric diseases that resemble naturally occurring illnesses but are more difficult to treat. Dependence occurs over a period of escalating use (Figure). Long-term exposure to the drug has been shown to cause severe neurotoxic and neuropathological effects with consequent disturbances in several cognitive domains.4

Despite advances in understanding the basic neurobiology of methamphetamine-induced effects on the brain, much remains to be done to translate this knowledge to treating patients and the complications that result from chronic abuse of this stimulant. In this review, we:
  • provide a brief synopsis of the clinical presentation of patients who use methamphetamine
  • describe some of the complications of methamphetamine abuse/dependence, focusing on methamphetamine-induced psychosis
  • suggest ways to approach the treatment of these patients, including those with methamphetamine-induced psychosis.


Recommended Reading

Chronic passive exposure to cannabis smoke linked to dependence
MDedge Psychiatry
From cells to socioeconomics, meth worsens HIV outcomes
MDedge Psychiatry
Are we on the verge of a cocaine epidemic?
MDedge Psychiatry
As nations advance economically, mental illnesses exact greater burdens
MDedge Psychiatry
‘Self-anesthetizing’ to cope with grief
MDedge Psychiatry
Psychiatric illness, low IQ often co-occur among male inmates
MDedge Psychiatry
VIDEO: How to manage surgical pain in opioid addiction treatment
MDedge Psychiatry
Home induction viewed as OK with Suboxone
MDedge Psychiatry
Psoriasis patients face higher risk of alcohol-related death – but lower suicide risk
MDedge Psychiatry
Fentanyl analogues an increasing factor in opioid deaths
MDedge Psychiatry